Related Experiment Video
Updated: May 25, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
[Treatment of chronic kidney disease: therapeutic strategy]
Xavier Belenfant1, Wided Tabbi Anani, Mélanie Roland
1Hôpital André-Grégoire, service de néphrologie dialyse, 93100 Montreuil-sous-Bois, France. xavier.belenfant@chi-andre-gregoire.fr
Insights
Slowing chronic kidney disease (CKD) progression involves managing cardiovascular risk factors and complications. Key targets include blood pressure and proteinuria, with ACE inhibitors as a primary treatment, alongside lifestyle changes.
Area of Science:
- Nephrology
- Cardiology
Context:
- Chronic kidney disease (CKD) is a progressive condition with significant cardiovascular risks.
- Effective management aims to slow disease progression and mitigate complications.
Purpose:
- To outline objectives for managing CKD, including slowing progression, addressing cardiovascular risk factors, treating complications, and preparing for renal replacement therapy.
- To define principal treatment targets for blood pressure and proteinuria.
Summary:
- The primary treatment strategy involves angiotensin-converting enzyme (ACE) inhibitors, lifestyle modifications, and dietary changes to achieve blood pressure <130/80 mmHg and proteinuria <0.5 g/day.
- Clinical and laboratory assessments are tailored to CKD stage and progression rate.
- Comprehensive, multidisciplinary management is crucial for patient outcomes.
Impact:
- Comprehensive management can halt or slow CKD progression.
- Reduces cardiovascular complications, the leading cause of mortality in CKD patients.
- Improves long-term patient prognosis and quality of life.
Abstract:
The objectives are to slow the progression of chronic kidney disease (CKD), to take all the cardiovascular risk factors into account, to screen for and treat specific complications and to prepare, if necessary, for renal replacement treatment (transplantation or dialysis). The principal treatment targets are: blood pressure less than 130/80 mmHg and proteinuria less than 0.5 g/day (ratio of proteinuria/creatinuria <50mg/mmol). The first-line treatment to reach these goals is angiotensin conversion enzyme inhibitors (ACE inhibitors), combined with diet and other life style changes. The periodicity of clinical and laboratory assessments depends on the CKD stage, the speed of disease progression and the need to reassess the impact of therapeutic interventions. Comprehensive multidisciplinary management can slow or even stop the progression of CKD and reduce its cardiovascular complications, which are the leading cause of death in these patients.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention